AI reads scans to spot hidden cancer spread

NCT ID NCT07183124

Not yet recruiting Diagnosis Sponsor: Taichung Veterans General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests an AI-powered 3D imaging model to improve detection of cancer spread in patients with stage II-III rectal cancer. Researchers will analyze existing CT and MRI scans from 1,500 patients to see if the AI can predict whether the cancer has reached the edge of the tissue removed during surgery. The goal is to help doctors plan more precise treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-Assisted 3D Imaging Model
What this could lead to: If successful, this AI tool could help doctors more accurately detect if rectal cancer has spread to nearby tissues, leading to better surgical planning and outcomes.
What could go wrong: This is a retrospective study using existing images, not a real-time test. The AI may not perform as well in different hospitals or with different scanners.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERAL SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENERAL SURGERY MEDICAL INFORMATICS ONCOLOGY

Contacts and locations

Locations

Taichung Veterans General Hospital

Taichung, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.